We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
Topics Covered
- Current understanding of the genetic basis of ALS
- Overview of the ALS Identified genetic testing program
- Key findings from the 2024 study analysing program data
- The role of genetic counselling and testing in the ALS care journey
- How increased access to genetic testing could shape future ALS research and clinical practice
Biography
Dr. Teresa Fecteau is Director of Medical Affairs with the Biogen US Medical Rare Disease Team. She leads strategy, planning, and implementation efforts, for Amyotrophic Lateral Sclerosis (ALS) and Spinal Muscular Atrophy (SMA). Dr. Fecteau received her PhD in Clinical Psychology from the University of Maine and completed a specialization in Behavioral Medicine/Medical Psychology during residency and post-doctoral fellowship at the Duke University School of Medicine. She has extensive experience as a clinician, medical educator, researcher, and leader within the pharmaceutical industry, academic medicine, and VA/DoD environments, with the past decade largely focused on Rare Neuromuscular Diseases and driving awareness of the overarching importance of equitable access to empirically driven multidisciplinary care for chronic, intractable illnesses.
Links
Series:
Categories:
Talk Citation
Fecteau, T. (2025, June 30). Advancing ALS genetics through accessible testing [Audio file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved July 1, 2025, from https://doi.org/10.69645/BBFX3011.Export Citation (RIS)
Publication History
- Published on June 30, 2025
Financial Disclosures
- Dr. Teresa Fecteau has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.